Canada Gazette
www.gazette.gc.ca
Common menu bar links
Vol. 142, No. 52 — December 27, 2008
ARCHIVED — COMMISSIONS
CANADA-NEWFOUNDLAND AND LABRADOR
OFFSHORE PETROLEUM BOARD
CANADA-NEWFOUNDLAND ATLANTIC ACCORD IMPLEMENTATION ACT
Call for Bids No. NL08-3
The Canada-Newfoundland and Labrador Offshore Petroleum Board hereby gives notice of the bid which has been selected in response to Call for Bids No. NL08-3 in the Newfoundland and Labrador Offshore Area. A summary of the terms and conditions applicable to the call was published in the Canada Gazette, Part I, on July 12, 2008.
This notice is made pursuant to and subject to the Canada-Newfoundland Atlantic Accord Implementation Act, S.C. 1987, c. 3, and the Canada-Newfoundland and Labrador Atlantic Accord Implementation Newfoundland and Labrador Act, R.S.N.L. 1990, c. C-2.
Pursuant to Call for Bids No. NL08-3, bids were to be submitted in a prescribed form and were to contain only the information required on this form. In accordance with this requirement, the following bid was conditionally selected. Subject to ministerial approval, the Board will issue an Exploration Licence for the parcel in January 2009:
|
Parcel No. 1 |
||
|---|---|---|
|
Work Expenditure Bid |
$1,800,000.00 |
|
|
Bid Deposit |
$10,000.00 |
|
|
Bidders, with participating shares |
Husky Oil Operations Limited |
100% |
|
Designated Representative |
Husky Oil Operations Limited |
Further information, including the full text of the Call for Bids No. NL08-3, may be obtained by contacting Ms. Susan Gover, Legal and Land, Canada-Newfoundland and Labrador Offshore Petroleum Board, TD Place, 5th Floor, 140 Water Street, St. John’s, Newfoundland and Labrador A1C 6H6.
December 2008
MAX RUELOKKE, P.Eng.
Chairman and Chief Executive Officer
[52-1-o]
CANADA-NEWFOUNDLAND AND LABRADOR
OFFSHORE PETROLEUM BOARD
CANADA-NEWFOUNDLAND ATLANTIC ACCORD IMPLEMENTATION ACT
Call for Bids No. NL08-4
The Canada-Newfoundland and Labrador Offshore Petroleum Board hereby gives notice of the bid which has been selected in response to Call for Bids No. NL08-4 in the Newfoundland and Labrador Offshore Area. A summary of the terms and conditions applicable to the call was published in the Canada Gazette, Part I, on July 12, 2008.
This notice is made pursuant to and subject to the Canada-Newfoundland Atlantic Accord Implementation Act, S.C. 1987, c. 3, and the Canada-Newfoundland and Labrador Atlantic Accord Implementation Newfoundland and Labrador Act, R.S.N.L. 1990, c. C-2.
Pursuant to Call for Bids No. NL08-4, bids were to be submitted in a prescribed form and were to contain only the information required on this form. In accordance with this requirement, the following bid was conditionally selected. Subject to ministerial approval, the Board will issue an Exploration Licence for the parcel in January 2009:
|
Parcel No. 1 |
||
|---|---|---|
|
Work Expenditure Bid |
$600,000.00 |
|
|
Bid Deposit |
$10,000.00 |
|
|
Bidders, with participating shares |
PDI Production Inc. |
100% |
|
Designated Representative |
PDI Production Inc. |
Further information, including the full text of the Call for Bids No. NL08-4, may be obtained by contacting Ms. Susan Gover, Legal and Land, Canada-Newfoundland and Labrador Offshore Petroleum Board, TD Place, 5th Floor, 140 Water Street, St. John’s, Newfoundland and Labrador A1C 6H6.
December 2008
MAX RUELOKKE, P.Eng.
Chairman and Chief Executive Officer
[52-1-o]
CANADIAN RADIO-TELEVISION AND
TELECOMMUNICATIONS COMMISSION
NOTICE TO INTERESTED PARTIES
The following notices are abridged versions of the Commission’s original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:
— Central Building, Les Terrasses de la Chaudière, Room 206, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, 819-997-2429 (telephone), 994-0423 (TDD), 819-994-0218 (fax);
— Metropolitan Place, Suite 1410, 99 Wyse Road, Dartmouth, Nova Scotia B3A 4S5, 902-426-7997 (telephone), 426-6997 (TDD), 902-426-2721 (fax);
— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, 204-983-6306 (telephone), 983-8274 (TDD), 204-983-6317 (fax);
— 530–580 Hornby Street, Vancouver, British Columbia V6C 3B6, 604-666-2111 (telephone), 666-0778 (TDD), 604-666-8322 (fax);
— CRTC Documentation Centre, 205 Viger Avenue W, Suite 504, Montréal, Quebec H2Z 1G2, 514-283-6607 (telephone), 283-8316 (TDD), 514-283-3689 (fax);
— CRTC Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, 416-952-9096 (telephone), 416-954-6343 (fax);
— CRTC Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, 306-780-3422 (telephone), 306-780-3319 (fax);
— CRTC Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, 780-495-3224 (telephone), 780-495-3214 (fax).
Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.
Secretary General
CANADIAN RADIO-TELEVISION AND
TELECOMMUNICATIONS COMMISSION
DECISIONS
The complete texts of the decisions summarized below are available from the offices of the CRTC.
2008-355 December 16, 2008
Wesley United Church Radio Board
St. John’s, Newfoundland and Labrador
Approved — Renewal of the broadcasting licence for the religious radio station VOWR St. John’s, from January 1, 2009, to August 31, 2012.
2008-348-1 December 17, 2008
CJNE-FM Radio Inc.
Nipawin, Saskatchewan
Correction — The Commission corrects Broadcasting Decision 2008-348 by deleting all references to the transmitter VF2212 Carrot River.
[52-1-o]
CANADIAN RADIO-TELEVISION AND
TELECOMMUNICATIONS COMMISSION
PUBLIC HEARING 2008-13-4
Notice of consultation and hearing
December 16, 2008
Gatineau, Quebec
Items 5 and 7 are withdrawn from this public hearing.
Further to Broadcasting Notices of Public Hearing CRTC 2008-13 dated October 17, 2008, CRTC 2008-13-1 dated October 24, 2008, CRTC 2008-13-2 dated November 17, 2008, and CRTC 2008-13-3 dated November 25, 2008, the Commission announces that the following items are withdrawn from this public hearing and that they will be rescheduled at a later date.
Item 5
Amherst, Nova Scotia
Application No. 2008-0816-5
Application by Maritime Broadcasting System Limited to convert radio station CKDH Amherst from the AM band to the FM band.
The Commission inadvertently indicated that the new station would operate on frequency 107.1 MHz. The frequency should have read 101.7 MHz.
Item 7
Laval, Sainte-Thérèse, Oka, Deux-Montagnes, Boisbriand,
Saint-Eustache, Blainville, Rosemère, Lorraine,
Bois-des-Fillions, Quebec
Application No. 2008-0844-6
Application by Télévision Régionale de Laval inc. for a licence to operate a low-power non-profit French-language community television programming undertaking in Laval and certain neighbouring communities.
December 15, 2008
[52-1-o]
CANADIAN RADIO-TELEVISION AND
TELECOMMUNICATIONS COMMISSION
PUBLIC HEARING 2008-14-4
Notice of consultation and hearing
January 26, 2009
Orillia, Ontario
The deadline for submission of interventions and/or comments, for this application only, is December 30, 2008.
Further to Broadcasting Notices of Public Hearing CRTC 2008-14 dated November 13, 2008, CRTC 2008-14-1 dated November 27, 2008, CRTC 2008-14-2 dated December 4, 2008, and CRTC 2008-14-3 dated December 11, 2008, the Commission announces that it will also consider the following application:
Preamble for item 40
This application will be considered, subject to interventions, in the non-appearing phase of the public hearing. The Commission will consider the interventions and replies relating to this application already placed on the public file for Broadcasting Notice of Public Hearing CRTC 2008-13.
40. Amherst, Nova Scotia
Application No. 2008-0816-5
Application by Maritime Broadcasting System Limited to convert the radio station CKDH Amherst from the AM band to the FM band.
December 16, 2008
[52-1-o]
CANADIAN RADIO-TELEVISION AND
TELECOMMUNICATIONS COMMISSION
PUBLIC NOTICE 2008-118
Notice of consultation
Applications received
Various locations
Deadline for submission of interventions and/or comments: January 20, 2009
The Commission has received the following applications:
1. Shaw Communications Inc., on behalf of Shaw Cablesystems
Limited and Videon Cablesystems Inc.
Various locations across Canada
To amend the broadcasting licences of its Class 1, Class 2 and Class 3 cable broadcasting distribution undertakings (BDUs) serving various locations in Canada.
2. AdrenalineHD Inc.
Across Canada
To amend the broadcasting licence of the national English-language Category 2 high-definition (HD) specialty programming undertaking known as Rush HD.
3. Amie du Quartier
Saint-Jérôme, Quebec
The licensee proposes to amend the authorized contours of CFND-FM by increasing the effective radiated power from 3.16 W to 49 W and the effective height of antenna above average terrain from 23 m to 28.4 m. All other technical parameters remain unchanged.
December 16, 2008
[52-1-o]
HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION
HAZARDOUS MATERIALS INFORMATION REVIEW ACT
Decisions and orders on claims for exemption
Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.
|
Claimant |
Product Identifier |
Registry Number |
MSDS Preparation Date (As shown on the MSDS) |
Date of Decision |
|---|---|---|---|---|
|
Cytec Industries Inc., West Paterson, New Jersey |
CYCOMÒ 97714A/ |
6229 |
07/08/2005 |
July 31, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCHCAL |
6236 |
21/07/2005 |
July 3, 2008 |
|
3M Canada Company, London, Ontario |
3M(TM) BRAND |
6284 |
2007/10/31 |
June 18, 2008 |
|
BYK-Chemie USA Inc., Wallingford, Connecticut |
Disperbyk-112 |
6419 |
02/23/2006 |
August 29, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
CYCOMÒ 7277 |
6421 |
01/17/2006 |
July 31, 2008 |
|
Enthone Inc., West Haven, Connecticut |
BLACK PEARLÒ ADJUSTER |
6427 |
4/20/2007 |
August 28, 2008 |
|
Enthone Inc., West Haven, Connecticut |
BLACK PEARLÒ MAINTENENCE |
6428 |
4/20/2007 |
August 28, 2008 |
|
Enthone Inc., West Haven, Connecticut |
SOLDEREXÒ TB-A |
6456 |
4/23/2007 |
July 10, 2008 |
|
Enthone Inc., West Haven, Connecticut |
RHODEXÒ BRIGHT RHODIUM CONCENTRATE |
6459 |
4/23/2007 |
September 9, 2008 |
|
3M Canada Company, London, Ontario |
3M(TM) SCREEN PRINTING UV INK SERIES 9800CL SCREEN PRINT |
6496 |
2007-06-27 |
July 14, 2008 |
|
Schlumberger Canada Limited, Calgary, Alberta |
Sulfate Scale Dissolver U 104 |
6533 |
22 April 2008 (English) |
September 9, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
CAN-1201 |
6535 |
May 23, 2008 (English) |
June 6, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
CAN-1200 |
6536 |
May 23, 2008 (English) |
June 24, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
CAN-1203 |
6537 |
May 23, 2008 (English) |
June 24, 2008 |
|
GE Betz Canada Inc., Mississauga, Ontario |
PROSHIELD 61N |
6556 |
26-NOV-2007 |
July 7, 2008 |
|
GE Betz Canada Inc., Mississauga, Ontario |
PROCHEM 2X31 |
6557 |
4-MAY-2006 |
July 9, 2008 |
|
GE Betz Canada Inc., Mississauga, Ontario |
PROSWEET |
6559 |
03-JAN-2008 |
July 7, 2008 |
|
GE Betz Canada Inc., Mississauga, Ontario |
PROCHEM |
6561 |
06-NOV-2007 |
June 30, 2008 |
|
Chevron Oronite Company LLC, Bellarie, Texas |
OLOA 55417 |
6564 |
05/03/2006 |
July 22, 2008 |
|
Rohm and Haas Canada LP, |
ADCOTE (tm) |
6579 |
02/15/2008 |
July 25, 2008 |
|
Rohm and Haas Canada LP, |
ADCOTE (TM) 37P295HV |
6580 |
04/27/2006 |
July 25, 2008 |
|
Rohm and Haas Canada LP, |
ADCOTE (TM) |
6581 |
04/27/2006 |
July 25, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6591 |
01/12/2007 |
August 25, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6592 |
04/27/2006 |
July 31, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6593 |
04/27/2006 |
July 31, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6595 |
04/27/2006 |
July 31, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6596 |
04/27/2006 |
July 31, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6599 |
06/01/2007 |
July 31, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID (TM) |
6601 |
04/27/2006 |
August 25, 2008 |
|
Cognis Canada Corporation, Mississauga, Ontario |
DSX 3515 |
6609 |
12/04/2007 |
July 3, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
FORTISÒ EC3056A formerly EC3056A |
6614 |
2008/04/06 |
September 29, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
EC3081A |
6615 |
2008/04/08 |
September 29, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
EC3264A formerly Prism EC3264A |
6616 |
2008/04/06 |
September 29, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
FLEXSORB SE EC9016A |
6619 |
2008/04/08 |
September 9, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCH-WELD (TM) AF-325 LS BLUE |
6623 |
2006-11-17 |
August 12, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCH-WELD (TM) AF-325 BLUE |
6624 |
2006-05-17 |
August 12, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
REDICOTEÒ E-11 E |
6628 |
05/04/2006 |
September 10, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
PETROÒ 11 |
6630 |
5/15/2006 |
July 29, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
PETROÒ BA POWDER formerly Petro (R) |
6631 |
5/15/2006 |
July 29, 2008 |
|
GE Betz Canada Inc., Mississauga, Ontario |
STYREX 3306 |
6647 |
27-JUL-2007 |
September 22, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCHWELD |
6651 |
2006/06/22 |
September 30, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
REDICOTEÒ E-64R E |
6653 |
06/13/2006 |
September 10, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
ARMEENÒ PF-1 |
6663 |
June 26, 2006 |
July 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
ARMEENÒ PF-30 |
6664 |
June 26, 2006 |
July 31, 2008 |
|
Chevron Oronite Company LLC, Bellarie, Texas |
OLOA 55419 |
6666 |
September 13, 2006 |
July 22, 2008 |
|
Acheson Colloids Company, |
EMRALON 8370C |
6671 |
3/08/2006 (English) |
July 8, 2008 |
|
Acheson Colloids Company, |
TW-035 |
6672 |
6/05/2008 |
September 12, 2008 |
|
Acheson Colloids Company, |
Emralon 305 |
6681 |
4/18/2006 (English) |
June 25, 2008 |
|
Acheson Colloids Company, |
LUMIDAG EL-041 |
6684 |
3/29/2007 (English) |
July 8, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
BEROLÒ 563 SA formerly Berol 563SA |
6695 |
7-19-2006 |
September 10, 2008 |
|
Chevron Oronite Company LLC, Bellarie, Texas |
OLOA 1299W |
6697 |
August 22, 2006 |
July 29, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPIKURE™ 3290 Curing Agent |
6698 |
06/02/2007 |
September 29, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
WITBREAK™ RTC 330 formerly Witbreak RTC 330 |
6716 |
9/29/2006 |
July 29, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCH-WELD(TM) EPOXY ADHESIVE DP-4XL-EG (PART A) |
6717 |
2007/11/19 |
June 18, 2008 |
|
BYK-Chemie USA Inc., Wallingford, Connecticut |
Anti-TerraÒ - U 100 |
6722 |
12/11/2007 |
September 22, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPIKURE™ Curing Agent 6870-W-53 |
6729 |
06/03/2007 |
August 11, 2008 |
|
Baker Petrolite Corporation, Sugar Land, Texas |
CGW3360 CORROSION INHIBITOR |
6735 |
10/23/2006 |
September 29, 2008 |
|
Baker Petrolite Corporation, Sugar Land, Texas |
CGW9994 CORROSION INHIBITOR |
6736 |
10/23/2006 |
September 29, 2008 |
|
E. I. duPont Canada Company, Mississauga, Ontario |
Dupont (TM) Cyrel |
6740 |
25-OCT-2006 |
September 22, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
BEROLÒ 505 |
6742 |
11/03/2006 |
June 30, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
BEROLÒ 508 |
6743 |
05/15/2007 |
June 30, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
CLASTA XP |
6746 |
2008/06/23 |
August 26, 2008 |
|
Raybo Chemical Company, Huntington, West Virginia |
RAYBO 82 |
6748 |
Oct31/07 (English) OCT31/07 (French) |
August 11, 2008 |
|
Raybo Chemical Company, Huntington, West Virginia |
RAYBO 41 |
6749 |
Oct31/07 (English) OCT31/07 (French) |
August 11, 2008 |
|
Cognis Canada Corporation, Mississauga, Ontario |
PHOTOMER 5010 F |
6767 |
02/07/2008 |
September 19, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
BRÒ 127 Corrosion Inhibiting Primer, |
6770 |
07/31/2006 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 377U Adhesive Film |
6771 |
07/24/2006 |
August 28, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 377S Adhesive Film |
6772 |
07/24/2006 |
August 28, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 490A Adhesive Foam |
6774 |
11/21/2006 |
September 15, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
CYCOMÒ 985 |
6775 |
07/31/2006 |
September 15, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
MX 2600 Bias |
6776 |
02/03/2006 |
August 28, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 284-N radiation curing |
6778 |
11/16/2006 |
September 15, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 1259 radiation curing |
6779 |
06/19/2008 |
September 29, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 8800 radiation curing |
6780 |
06/19/2008 |
September 30, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 8803 radiation curing |
6781 |
06/19/2008 |
September 30, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
NALCO(R) 8316 |
6783 |
2008/06/23 |
August 26, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
HTÒ 424 Adhesive Film |
6791 |
04/12/2007 |
September 12, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 1000 Adhesive Film |
6792 |
02/22/2006 |
September 15, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 300 Adhesive Film |
6793 |
06/12/2007 |
September 30, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 300-2 Adhesive Film |
6794 |
04/12/2007 |
September 30, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 350 NA Adhesive Film |
6795 |
12/18/2006 |
September 12, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 410 Core |
6797 |
12/18/2006 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 410-1 |
6798 |
04/12/2007 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 1015 |
6799 |
12/18/2006 |
September 12, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
FMÒ 1015-U |
6800 |
12/18/2006 |
September 12, 2008 |
|
MeadWestvaco Corporation, Covington, Virginia |
NUCHARÒ WV-IS XL SPECIALTY TREATED ACTIVATED CARBON formerly Nuchar WV-IS XL Specialty Treated Activated Carbon |
6809 |
12/15/2006 |
July 16, 2008 |
|
R. T. Vanderbilt Company Inc., Norwalk, Connecticut |
VANLUBEÒ 672 |
6813 |
2/4/2008 |
July 8, 2008 |
|
BYK-Chemie USA Inc., Wallingford, Connecticut |
Anti-Terra-203 |
6817 |
01/10/2007 |
September 22, 2008 |
|
Cognis Canada Corporation, Mississauga, Ontario |
DEHYPOUND ADVANCED |
6821 |
02/13/2008 |
September 19, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-0422 COLORTRENDÒ MAGENTA formerly AquatrendÒ Plus™ 870-0422 COLORTRENDÒ MAGENTA |
6826 |
03/10/2008 |
September 30, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-0825 COLORTRENDÒ HIGH PERFORMANCE RED formerly AquatrendÒ Plus™ 870-0825 COLORTRENDÒ HIGH PERFORMANCE RED |
6827 |
03/10/2008 |
September 30, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-0832 COLORTRENDÒ ORGANIC RED formerly AquatrendÒ Plus™ 870-0832 COLORTRENDÒ ORGANIC RED |
6828 |
03/10/2008 |
September 30, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-0842 COLORTRENDÒ ORGANIC RED formerly AquatrendÒ Plus™ 870-0842 COLORTRENDÒ ORGANIC RED |
6829 |
03/10/2008 |
September 30, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-1045 COLORTRENDÒ |
6830 |
03/10/2008 |
September 30, 2008 |
|
Evonik Degussa Canada Inc., Brampton, Ontario |
870-1572 COLORTRENDÒ I BROWN OXIDE formerly AquatrendÒ Plus™ 870-1572 COLORTRENDÒ I BROWN OXIDE |
6831 |
03/10/2008 |
September 30, 2008 |
|
Chevron Products Company, Richmond, California |
Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 418 |
6849 |
February 11, 2008 |
September 29, 2008 |
|
Chevron Products Company, Richmond, California |
Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 422 |
6850 |
February 11, 2008 |
September 29, 2008 |
|
Chevron Products Company, Richmond, California |
Chevron IDWÒ ISODEWAXINGÒ Catalyst ICR 424
|
6851 |
February 11, 2008 |
September 29, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
IRCOGELÒ 905 |
6852 |
16 October 2007 |
September 4, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
ANGLAMOLÒ 6043P |
6853 |
16 October 2007 |
September 4, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
ANGLAMOLÒ 9001N |
6854 |
05 April 2007 |
September 4, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario |
PARCOSOL 577 WB |
6857 |
Feb25/08 |
August 7, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario |
PARCOSOL 570 WB |
6858 |
Feb25/08 |
August 7, 2008 |
|
Baker Petrolite Corporation, Sugar Land, Texas |
CRW9124 CORROSION INHIBITOR |
6859 |
1/12/2007 |
September 29, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
TST-602 |
6864 |
2008/06/10 |
August 19, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 8403 radiation curing |
6871 |
06/19/2008 |
September 30, 2008 |
|
Nalco Canada Co., Burlington, Ontario |
EC9092A Process Antifoulant |
6887 |
2008/06/23 |
August 21, 2008 |
|
Chevron Oronite Company LLC, Bellarie, Texas |
OLOA 55008 |
6890 |
February 12, 2007 |
July 22, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
SOLSPERSEÒ 20000 |
6891 |
05 June 2007 |
July 30, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
SOLSPERSEÒ 41000 |
6892 |
28 May 2008 |
July 30, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
SOLSPERSEÒ 41090 |
6893 |
21 November 2007 |
July 30, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
EBECRYLÒ 9312 radiation curing |
6899 |
03/08/2007 |
September 30, 2008 |
|
Cognis Canada Corporation, Mississauga, Ontario |
CAPCURE 40 SECHV |
6900 |
02/23/2007 |
September 19, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario |
P3 FORGE 4774 |
6927 |
Feb25/08 |
August 7, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOLÒ 5782S |
6950 |
03 January 2008 |
September 4, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
BRÒ 227 Primer |
6955 |
09/30/2005 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
BRÒ 227 Pour Coat 30% Solids |
6956 |
06/04/2004 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
BRÒ 227A Primer |
6957 |
06/16/2005 |
September 18, 2008 |
|
Cytec Industries Inc., West Paterson, New Jersey |
BRÒ 1009-49 Tack Primer |
6959 |
06/04/2004 |
September 18, 2008 |
|
Chevron Oronite Company LLC, Bellarie, Texas |
OLOA 5653 |
6969 |
June 13, 2007 |
August 28, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
REDICOTEÒ C-404 |
6971 |
5/15/2007 |
August 29, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
ARMOHIBÒ 31 |
6972 |
5/15/2007 |
September 2, 2008 |
|
Cansolv Technologies Inc., |
CANSOLV™ |
7034 |
2008-03-27 |
September 29, 2008 |
|
Cognis Canada Corporation, Mississauga, Ontario |
WATERPOXY 751 |
7068 |
07/02/2007 |
September 19, 2008 |
|
Taminco Higher Amines Inc., Allentown, Pennsylvania |
ADVANTEX (R) |
7077 |
14 AUG 2006 |
September 2, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPIKURE™ 3164 Curing Agent |
7082 |
07/20/2007 |
September 29, 2008 |
|
Pulcra Chemicals LLC, Charlotte, North Carolina |
KATAX 6660-A |
7087 |
05/01/2008 |
September 3, 2008 |
|
Arkema Canada Inc., Oakville, Ontario |
THERMOLITEÒ |
7092 |
08/13/07 |
August 13, 2008 |
|
Taminco Higher Amines Inc., Allentown, Pennsylvania |
VANTEXÒ T |
7096 |
01/31/08 |
September 2, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOLÒ |
7113 |
23 August 2007 |
August 28, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
WITCONATE ™ |
7174 |
07/14/2008 |
September 22, 2008 |
|
Dow Chemical Canada Inc., Calgary, Alberta |
CANSOLV (TM) Absorbent DM/ABSORBANT CANSOLV(MC) DM |
7249 |
2008.02.28 |
September 4, 2008 |
|
Dow Chemical Canada Inc., Calgary, Alberta |
TRITON(TM) |
7250 |
2008.04.01 |
September 17, 2008 |
|
Dow Chemical Canada Inc., Calgary, Alberta |
UCARSOL(TM) HS SOLVENT 101/SOLVANT UCARSOL(MC) |
7252 |
2008.02.21 |
September 4, 2008 |
Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6236 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
2. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6284 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
3. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6496 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.
4. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6533 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
5. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6535 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of one ingredient. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.
6. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6536 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of four ingredients. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.
7. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6537 to be the chemical identity and chemical name, common name, generic name, trade name or brand name of a controlled product of five ingredients. The subject of the claim on which the screening officer issued the decision is the trade name or brand name of a controlled product.
8. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6601 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
9. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6614 as EC3056A. The correct product identifier is FORTIS® EC3056A.
10. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6616 as Prism EC3264A. The correct product identifier is EC3264A.
11. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6651 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
12. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6698 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
13. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6729 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and the concentration of one ingredient.
14. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claims bearing Registry Numbers 6772, 6775 and 6776 to be the chemical identity of three ingredients. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of two, four and two ingredients, respectively.
15. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Numbers 6797 and 6798 to be the chemical identity of four ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.
16. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6800 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
17. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6821 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.
18. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Number 6857 and 6858 to be the chemical identity and the concentration of one ingredient. The subject of the claims on which the screening officer issued the decisions is the chemical identity of one ingredient.
19. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, listed the subject of the claim bearing Registry Number 6927 to be the chemical identity and the concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
20. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, incorrectly listed the subject of the claim bearing Registry Number 6950 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
21. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 7034 as CANSOLV™ DC-103 Solvent. The correct product identifier is CANSOLV™ DC-103 A Solvent.
There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs.
Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the MSDSs in respect of which the claims bearing Registry Numbers 6564, 6592, 6593, 6595, 6596, 6599, 6609, 6614, 6615, 6616, 6697, 6722, 6735, 6736, 6742, 6743, 6746, 6779, 6783, 6809, 6817, 6853, 6859, 6864, 6871, 6887, 6969, 7113, 7249 and 7252 were filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
In the case of the claim bearing Registry Number 6533, being a claim from an employer in the province of Alberta, the screening officer found that the MSDS relating to this claim did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta.
In the case of the claims bearing Registry Numbers 6535, 6536 and 6537, being claims from an employer in the province of Alberta, the screening officer found that the MSDS in respect of which the claims were filed complied with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta while the labels in respect of which the claims were filed did not comply with the applicable disclosure requirements of the said act.
Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
Registry Number 6229
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of 2-butanone in the controlled product, its CAS Registry Number 78-93-3 and its percent concentration;
2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 300 ppm for 2-butanone.
Registry Number 6236
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose that the identity of ingredient acrylate binder is exempt from disclosure under HMIRC Registry Number 6236;
2. If 1,2,4-trimethylbenzene, naphthalene and ethylbenzene are disclosed on the MSDS, state that the ingredients are part of the complex mixture xylene;
3. Amend the first aid measures - Instructions for Eye Contact to advise that eyes should be flushed with large amounts of water for at least 20 minutes;
4. Amend the first aid measures - Instructions for Skin Contact subsection on the MSDS to state that skin should be flushed with large amounts of water for at least 20 minutes or until the chemical is removed. If breathing or the heart has stopped, trained personnel should immediately begin artificial respiration (AR) or cardiopulmonary resuscitation (CPR) respectively;
5. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;
6. Amend the MSDS to disclose the lower LC50 (4 hours, rat) of 2 639 ppm for the hazardous ingredient cyclohexanone;
7. Amend the MSDS to disclose the lower LD50 (oral, rat) value of 3 523 mg/kg for the hazardous ingredient xylene;
8. Amend the MSDS to correct the ACGIH exposure limits for the hazardous ingredient xylene;
9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
Registry Number 6284
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the identity and concentration of an additional ingredient with as much precision as possible;
2. Add instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 20 minutes or until the chemical is removed;
3. Add instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 20 minutes or until the chemical is removed;
4. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;
5. Amend the MSDS to disclose the ACGIH TLV–TWA exposure limit of 20 ppm for the hazardous ingredient toluene;
6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause colour vision loss;
7. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;
8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause permanent hearing loss in laboratory animals;
9. Disclose that toluene is potentiated by acetylsalicylic acid and n-hexane to produce irreversible auditory damage in laboratory animals.
Registry Number 6419
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose an acceptable WEEL TWA of 50 ppm for the ingredient methoxy-2-propanol acetate;
2. Amend the MSDS to disclose that ingestion of an ingredient in the product has been known to cause central nervous system depression in laboratory animals.
Registry Number 6421
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose the appropriate concentration or concentration range for two ingredients in the controlled product;
2. Disclose the presence of 2-butanone in the controlled product, its CAS Registry Number 78-93-3 and its percent concentration;
3. Disclose the Exposure Limit Values ACGIH TLV–TWA = 200 ppm and ACGIH TLV–STEL = 300 ppm for 2-butanone.
Registry Numbers 6427 and 6428
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;
2. Disclose that an ingredient in the controlled product caused eye corrosion;
3. Modify the MSDS to disclose the statement or information similar to wash with soap and water for at least 30 minutes;
4. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting the claim bearing Registry Number 6427, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6456
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the identity of the three secret ingredients with as much precision as possible;
2. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product;
3. Disclose oral LD50 values for two of the confidential hazardous ingredients in an acceptable manner;
4. Disclose an LC50 value for one of the confidential hazardous ingredients in an acceptable manner;
5. If the WHMIS classification of the controlled product is disclosed on the MSDS, then the MSDS should be modified to disclose that the controlled product also has the D2A classification, in addition to the classes that are already disclosed.
Registry Number 6459
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Modify the MSDS to recommend the wearing of appropriate protective equipment (e.g. goggles) to avoid eye contact when handling this product.
Registry Number 6496
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
3. Add oxides of carbon and nitrogen to the list of hazardous combustion products;
4. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
Registry Number 6533
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the identity and concentration of an additional ingredient with as much precision as possible;
2. Amend the MSDS by removing the ACGIH TLV designation for nuisance dust;
3. Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6535
The claimant has been ordered to amend certain aspects of the content of the label.
In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been further ordered to amend the label as indicated below.
1. Disclose on the label that inhalation may cause central nervous system depression;
2. Modify the label to disclose the wash time of at least 30 min-utes applicable to cases of skin contact;
3. Modify the label to disclose the longer wash time of 30 minutes applicable to cases of eye contact;
4. Modify the label to disclose which specific personal protection equipment should be used e.g. glove type/material, goggles;
5. Modify the label to recommend to keep the product away from incompatibles such as strong oxidizing agents, strong bases, and acids.
Registry Number 6536
In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose information required by law pertaining to the progress of the claim for exemption on the label;
2. Disclose on the label that inhalation/ingestion may cause central nervous system depression and/or death;
3. Modify the label to disclose the wash time of at least 30 minutes applicable to cases of skin contact;
4. Modify the label to disclose the longer wash time of 30 minutes applicable to cases of eye contact;
5. Remove the statement “Have victim drink 2 glasses of water”;
6. Modify the label to disclose which specific personal protection equipment should be used, e.g. glove type/material, goggles;
7. Modify the label to recommend to keep the product away from incompatibles such as strong oxidizing agents, strong bases, and acids.
Registry Number 6537
In the opinion of the screening officer, certain information should have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose information required by law pertaining to the progress of the claim for exemption on the label;
2. Disclose on the label that inhalation/ingestion may cause central nervous system depression and/or death;
3. Modify the label to disclose a wash time of at least 30 minutes applicable to cases of skin contact;
4. Modify the label to disclose a longer wash time of 30 minutes applicable to cases of eye contact;
5. Remove the statement “Have victim drink 2 glasses of water.”;
6. Modify the label to disclose which specific personal protection equipment should be used, e.g. glove type/material, goggles;
7. Modify the label to disclose that the product must be kept away from incompatible materials such as strong oxidizing agents, strong bases, and acids.
Registry Number 6556
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to clarify that the ingredient naphthalene is a component of the complex mixture solvent naphtha heavy aromatic;
2. Disclose the specific LD50 (species and route) for a CBI ingredient;
3. Amend the MSDS to disclose that thermal decomposition of the controlled product releases oxides of sulfur;
4. Disclose that the TLV (ACGIH) of 0.2 ppm for the CBI ingredient is the time weighted average (TWA) value.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6557
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to clarify that the ingredient naphthalene is a component of an aromatic mixture;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;
3. Disclose the specific LD50 (species and route) for a CBI ingredient;
4. Amend the MSDS to state a rinse time of at least 30 min or until the chemical is removed in the first aid advice for skin contact;
5. Amend the MSDS to state a rinse time of at least 30 min or until the chemical is removed in the first aid advice for eye contact;
6. To the first aid instructions, add a statement not to administer water unless under medical supervision. The advice to administer three to four glasses of liquid should be removed;
7. The MSDS should disclose that thermal decomposition of the controlled product releases oxides of carbon and oxide of sulfur.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6559
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the specific lower LD50 (species and route) of 4 g/kg for ethylene glycol;
2. Disclose that ingestion of an ingredient in the controlled product has affected central nervous, respiratory, circulatory and urinary systems;
3. Disclose the ACGIH TLV–C = 100 mg/m3 value for the ingredient ethylene glycol;
4. Disclose the ACGIH TLV–TWA Exposure Limit Value for the confidential hazardous ingredient.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6561
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to clarify that the ingredients naphthalene and 1,2,3,4 trimethylbenzene are components of the solvent naphtha, petroleum heavy aromatic;
2. Disclose the CAS registry number, the chemical identity and concentration of an ingredient on the MSDS.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6579
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.
Registry Number 6580
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.
Registry Number 6581
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Replace the first aid measures - Ingestion with instructions not to administer water unless in small amounts (250–300 mL) under medical supervision.
Registry Number 6591
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of sulphur to the list of hazardous combustion products.
Registry Number 6601
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 6619
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Modify the MSDS to disclose the longer flush time of at least 30 minutes in the first aid advice for eye contact;
2. Modify the MSDS to disclose the statement or information similar to “Wash with soap and water for at least 30 minutes” in the case of first aid advice for skin contact.
Registry Number 6623
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose an acceptable chemical identity of an ingredient;
2. Amend the MSDS to disclose consistent information regarding the possible mutagenic effects of the controlled product.
Registry Number 6624
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of crystalline silica, quartz in the controlled product and its CAS Registry Number 14808-60-7;
2. Disclose an ACGIH TLV–TWA of 0.025 mg/m3 (respirable) for the hazardous ingredient crystalline silica;
3. Disclose that an ingredient in the controlled product has been classified as probably carcinogenic to humans (Group 2A) by the International Agency for Research on Cancer (IARC) and has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);
4. Amend the MSDS to disclose consistent information regarding the possible mutagenic effects of the controlled product.
Registry Number 6628
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that ingestion of alcohol during pregnancy has caused birth defects in children;
2. Disclose that ingestion is a possible route of entry;
3. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;
4. Disclose an LC50 (rat) value of 31 600 ppm for the ingredient ethanol;
5. Disclose that acute ingestion of an ingredient has caused gastric ulceration in laboratory animals;
6. Disclose that long-term ingestion of an ingredient has caused an increase of triglycerides in the plasma, liver and heart with atrophy of heart bundle muscle fibres, fragmentation and loss of striation in laboratory animals;
7. Disclose that an ingredient has produced mutagenic effects in germ cells and somatic cells in vivo;
8. Disclose that an ingredient has caused synergistic and potentiating effects with a wide range of industrial chemicals.
Registry Number 6630
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should not have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to remove the TWA (ACGIH) of 10 mg/m3 for total inhalable dust and 3 mg/m3 for respirable fraction for a particulate not regulated;
2. Disclose that skin irritation has been observed in laboratory animals as a result of dermal exposure to an ingredient in the controlled product.
Registry Number 6631
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to remove the TWA (ACGIH) of 10 mg/m3 for total inhalable dust and 3 mg/m3 for respirable fraction for a particulate not regulated.
Registry Number 6647
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the concentration of hazardous ingredients in acceptable ranges according to the CPR 11;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;
3. Disclose on the MSDS that hearing loss has been observed in laboratory animals as a result of inhalation of an ingredient in the controlled product;
4. Amend the MSDS to state an increased rinse time of at least 20 minutes or until the chemical is removed in the first aid advice for skin contact;
5. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;
6. Disclose on the MSDS that fetotoxic effects have been observed in animals as a result of inhalation of an ingredient during pregnancy;
7. Disclose that an ingredient in the controlled product has produced mutagenic effects in mammalian cells in vitro;
8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6651
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an acceptable chemical identity for a hazardous ingredient;
2. Add instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 20 minutes or until the chemical is removed;
3. Add instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 20 minutes or until the chemical is removed;
4. Add instructions similar to the following to the first aid measures - Instructions for Inhalation: If the heart has stopped, trained personnel should immediately begin cardio-pulmonary resuscitation (CPR);
5. Disclose the lower LC50 (4 hours, female rat, vapour) of 19.0 mg/L for the hazardous ingredient toluene;
6. Amend the MSDS to correct the ACGIH exposure limit for the hazardous ingredient toluene and remove the skin notation;
7. Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause moderate irritation to the skin of laboratory animals;
8. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;
9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause colour vision loss;
10. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause hearing loss and altered immune function in laboratory animals;
11. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in yeast without metabolic activation, in vitro;
12. Disclose that ingredients in the controlled product have been shown to cause mutagenic effects in cultured mammalian cells, in vitro;
13. Amend the MSDS to disclose that an additional ingredient in the controlled product has been shown to cause birth defects or other reproductive harm;
14. Disclose that toluene is potentiated by acetylsalicylic acid and n-hexane to produce irreversible auditory damage in laboratory animals.
Registry Number 6653
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that ingestion of alcohol during pregnancy has caused birth defects in children;
2. Amend the MSDS to advise an increased rinse time of at least 30 minutes in the case of first aid advice for eye contact;
3. Amend the MSDS to incorporate an increased rinse time of at least 30 minutes in the case of first aid advice for skin contact;
4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source;
5. Disclose that acute ingestion of alcohol has caused gastric ulceration in laboratory animals;
6. Disclose that long term ingestion of alcohol has caused an increase of triglycerides in the plasma, liver and heart in laboratory animals;
7. Disclose that ethanol has produced mutagenic effects in germ cells and somatic cells in vivo;
8. Disclose that ethanol has caused synergistic and potentiating effects with a wide range of industrial chemicals;
9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Numbers 6663 and 6664
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose a lower LD50 value according to the regulations.
Registry Number 6671
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the identity, CAS registry number and concentration of another ingredient in the controlled product;
2. Disclose the current ACGIH TLV–TWA value of 200 ppm and the TLV–STEL of 250 ppm for an ingredient in the controlled product;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for 20 minutes or until the chemical is removed, contaminated clothing and footwear should be removed under running water, and medical advice should be obtained immediately;
4. Disclose LD50 values for the confidential hazardous ingredient in an acceptable manner;
5. Disclose on the MSDS that an ingredient in the controlled product has produced fetotoxic and teratogenic effects and significant behavioural abnormalities in the offspring of experimental animals at dose levels not producing maternal toxic effects;
6. Disclose on the MSDS that an ingredient in the controlled product has tested positive in screening tests for mutagenicity with and without metabolic activation.
Registry Number 6672
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the ACGIH TLV–STEL value of 250 ppm for the ingredient methanol;
2. Amend the MSDS to disclose additional advice to specify a wash time of 20 minutes or until the chemical is removed and expand the advice to remove contaminated clothing, shoes and leather goods and obtain medical attention immediately, upon skin contact with the controlled product;
3. Disclose LD50 values for the confidential hazardous ingredient in an acceptable manner;
4. Disclose on the MSDS that an ingredient in the controlled product causes mutagenic effects in animal and bacterial cells.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6681
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose the current exposure limits for these ingredients in the controlled product:
Xylene - ACGIH TLV–STEL - 150 ppm;
n-Amyl Acetate - ACGIH TLV–TWA - 50 ppm and ACGIH TLV–STEL 100 ppm;
Methanol - ACGIH TLV–STEL - 250 ppm;
Methyl Ethyl Ketone - ACGIH TLV–STEL - 300 ppm;
Isopropanol - ACGIH TLV–STEL - 400 ppm;
2. Amend the MSDS to disclose that the ACGIH TLV disclosed for the ingredient formaldehyde is a ceiling value;
3. Amend the MSDS to indicate that ethyl benzene is a part of the complex mixture xylene or remove the reference to ethyl benzene altogether;
4. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused CNS effects in male rabbits;
5. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused CNS effects, vision damage and gastrointestinal effects in humans;
6. Disclose on the MSDS that acute dermal exposure to an ingredient in the controlled product has caused acute renal failure in humans;
7. Disclose on the MSDS that acute ingestion of ingredients in the controlled product has caused lung damage, gastrointestinal, cardiovascular symptoms and CNS effects in humans;
8. Disclose on the MSDS that chronic inhalation exposure to an ingredient in the controlled product has caused lung fibrosis in animals;
9. Disclose on the MSDS that chronic inhalation exposure to an ingredient in the controlled product has caused hearing impairment in laboratory animals;
10. Amend the MSDS to advise a flush time of at least 30 minutes and to remove contaminated clothing, shoes and leather goods under running water in case of dermal contact with the controlled product;
11. Amend the MSDS to remove the instruction to induce vomiting by giving one tablespoon of syrup of ipecac or by sticking finger down throat, in case of ingestion of the controlled product;
12. Amend the MSDS to advise that if the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately; if breathing has stopped, trained personnel should administer artificial respiration immediately in case of ingestion of the controlled product and/or dermal contact in the case of methanol;
13. Add oxides of sulfur to the list of hazardous decomposition or combustion products;
14. Disclose the LD50 (oral, rat) value of 2.51 g/kg for the ingredient n-butyl alcohol;
15. Disclose the LD50 (oral, rat) value of 700 mg/kg for the ingredient n-amyl acetate;
16. Disclose the LD50 (oral, rat) value of 3 523 mg/kg for the ingredient xylene;
17. Disclose the LD50 (oral, rat) value of 2 900 mg/kg for the ingredient phenol-formaldehyde resin;
18. Disclose the LD50 (oral, rat) value of 10 600 mg/kg for the ingredient ethanol;
19. Disclose the LD50 (oral, rat) value of 13.0 mg/kg for the ingredient methanol;
20. Disclose the LD50 (oral, rat) value of 530 mg/kg for the ingredient phenol;
21. Disclose the LD50 (dermal, rabbit) value of 8 mL/kg for the ingredient isopropanol;
22. Disclose the LD50 (dermal, male rabbit) value of 9.51 mL/kg for the ingredient n-amyl acetate;
23. Disclose the LD50 (dermal, rabbit) value of 15 800 mg/kg for the ingredient methanol;
24. Disclose the LC50 (4 hours, rat, vapour) value of 17 000 ppm for the ingredient isopropanol;
25. Disclose the LC50 (4 hours, rat, vapour) value of 6 350 ppm for the ingredient xylene;
26. Disclose the LC50 (4 hours, rat, vapour) value of 6 750 mg/m3 for the ingredient carbon black;
27. Disclose the LC50 (4 hours, rat, vapour) value of 31 600 ppm for the ingredient ethanol;
28. Disclose the LC50 (4 hours, rat, vapour) value of 11 300 ppm for the ingredient methyl ethyl ketone;
29. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects without maternal toxicity in laboratory animals;
30. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects with maternal toxicity in laboratory animals;
31. Disclose on the MSDS that ingredients in the controlled product have caused teratogenic effects in human cells in vitro, in mammalian cells in vivo and in animal and bacterial cells;
32. Disclose on the MSDS the potentiation effects of n-hexane on the ingredient xylene to enhance hearing loss;
33. Disclose on the MSDS that the ingredient ethanol acts synergistically with trichloroethylene to reduce mental capacity and with N-butyraldoxime to cause CNS effects.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6684
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the current AIHA TWA exposure limit of 1 mg/m3 and the skin designation for the ingredient trimethylolpropane triacrylate;
2. Disclose that an ingredient in the controlled product is corrosive to the eyes of animals;
3. Disclose the LD50 (oral, rat) value of 5.19 mL/kg for the ingredient trimethylolpropane triacrylate;
4. Disclose the LD50 (dermal, rat) value of 6.35 mL/kg for the ingredient trimethylolpropane triacrylate;
5. Disclose the LC50 (4 hours, rat) value of 33 mg/L for the ingredient 4-chlorobenzotrifluoride;
6. Disclose on the MSDS that ingredients in the controlled product have tested positive in screening tests for mutagenicity with and without metabolic activation.
Registry Number 6695
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose carbon, nitrogen and sulfur as hazardous combustion or decomposition products.
Registry Number 6698
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the concentrations of all hazardous ingredients in an acceptable WHMIS format;
2. Amend the instructions in the first aid measures - Skin Contact to state: If breathing has stopped, trained personnel should begin artificial respiration (AR) immediately. If the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately;
3. Amend the MSDS to disclose oxides of carbon as hazardous combustion products;
4. Disclose an LD50 (oral, rat) value of 2.83 mL/kg (2.8 g/kg) and an LD50 (dermal, rabbit) value of 0.56 mL/kg (550 mg/kg) for the first hazardous ingredient polyethylenepolyamine;
5. Disclose an LD50 (oral, rat) value of 1.08 g/kg and an LD50 (dermal, rabbit) value of 0.707 mL/kg (675 mg/kg) for the second hazardous ingredient polyethylenepolyamine.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6716
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose that an acceptable concentration ingredient range applies to stated concentration range of the hazardous ingredients cited in formulation of the controlled product.
Registry Number 6717
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose more specific chemical identities for three hazardous ingredients;
2. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with large amounts of water for at least 30 minutes;
3. Amend instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with large amounts of water for at least 30 minutes;
4. Add instructions similar to the following to the first aid measures - Instructions on Ingestion: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give the victim two glasses of water;
5. Disclose storage information similar to the following: Store in tightly closed, corrosion-resistant containers. Store in cool, dry, well ventilated areas, out of direct sunlight and away from sources of heat. Avoid rapid temperature changes;
6. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in cultured mammalian cells, in vitro;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 6729
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose acceptable information for the concentration of the CBI ingredient;
2. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give water to drink, if the victim is conscious;
3. Amend the MSDS to disclose as hazardous combustion products: oxides of carbon and nitrogen.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6740
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose on the MSDS that dermal exposure to an ingredient in the controlled product has caused liver necrosis;
2. Disclose that dermal application of an ingredient in the controlled product has caused a strong anaesthetic effect;
3. The specific first aid instruction to give two glasses of water should be removed from the MSDS;
4. Amend the MSDS to disclose oxides of carbon as hazardous combustion products;
5. Disclose the LD50 values for the ingredient aliphatic C-8 ester according to the regulations;
6. Disclose the LC50 values for the ingredient isoparaffinic hydrocarbon according to the regulations;
7. Disclose the LD50 values for the ingredient benzyl alcohol according to the regulations.
Registry Number 6748
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of two additional confidential hazardous ingredients, along with their respective concentrations in an acceptable WHMIS format;
2. Disclose the ACGIH TLV–STEL exposure limit of 150 ppm for xylene;
3. Disclose the ACGIH TLV–TWA value of 200 ppm (skin) and the TLV–STEL value of 250 ppm (skin) for the hazardous ingredient methanol;
4. Disclose the ACGIH TLV–TWA value of 200 ppm and the TLV–STEL value of 400 ppm for the hazardous ingredient isopropanol;
5. Disclose the LD50 (oral, male rat) value of 3 523 mg/kg for the hazardous ingredient xylene;
6. Disclose the LD50 (oral, rat) value of 10 600 mg/kg for the hazardous ingredient ethanol;
7. Disclose an LC50 (4 hours, rat) value of 6 350 ppm for the hazardous ingredient xylene;
8. Disclose an LC50 (4 hours, rat) value for the hazardous ingredient ethanol;
9. Add the time frame of at least 15 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact;
10. Disclose that an ingredient of the controlled product has produced mutagenic effects in both germ and somatic cells of laboratory animals and has shown positive results in in vitro screening tests on human lymphocytes.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6749
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the ACGIH TLV–STEL exposure limit of 150 ppm for xylene;
2. Identify the disclosed exposure level limit for the confidential hazardous ingredient as being a ceiling limit and correct the information concerning the organization responsible for setting the limit;
3. Disclose the LD50 (oral, male rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for the hazardous ingredient xylene;
4. Disclose a dermal LD50 value for the confidential ingredient;
5. Add the time frame of at least 30 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact;
6. Add oxides of nitrogen to the list of hazardous combustion products;
7. Disclose that an ingredient in the controlled product has produced fetal injury in laboratory animals;
8. If the WHMIS classification is going to be shown, add the classifications of Class D, Division 1, Subdivision A and Class D, Division 2, Subdivision A. Remove the existing Class B, Division 3 and add the classification Class B, Division 2.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6767
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose eye contact as a route of entry;
2. Amend instructions similar to the following to the first aid measures - After Skin Contact: Immediately flush with plenty of water for 20 minutes or until the chemical is removed;
3. Amend the MSDS to disclose oxides of nitrogen as hazardous combustion products;
4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
Registry Number 6770
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of methanol in the controlled product, its CAS Registry Number 67-56-1 and its percent concentration;
2. Disclose on the MSDS that an ingredient in the controlled product causes teratogenic/fetotoxic effects in the absence of maternal toxicity.
Registry Numbers 6771 and 6772
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.
Registry Number 6774
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 6775
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 6776
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;
2. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
3. Disclose on the MSDS that chronic exposure to an ingredient in the controlled product has caused kidney problems and testicular effects in laboratory animals;
4. Amend the MSDS to disclose the lower (oral, rat) LD50 value of 340 mg/kg for the ingredient phenol.
Registry Number 6778
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to advise that if breathing has stopped, trained personnel should begin artificial respiration and if the heart has stopped, trained personnel should begin cardiopulmonary resuscitation, immediately, in case of skin contact with the controlled product;
2. Amend the MSDS to disclose the correct value of 1.18 g/mL at 25°C under the heading Specific Gravity/Density;
3. Disclose on the MSDS that an ingredient in the controlled product has shown mutagenic effects in mouse lymphoma cells;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
Registry Number 6780
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed.
Registry Number 6781
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of nitrogen to the list of hazardous decomposition or combustion products.
Registry Number 6791
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose a lower LD50 (oral, rat) value of 340 mg/kg for phenol.
Registry Number 6792
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose on the MSDS that an ingredient in the controlled product has the IARC Group 2B classification;
2. Disclose on the MSDS the current OSHA PEL value of 10 mg/m3 for the hazardous ingredient titanium dioxide.
Registry Numbers 6793 and 6794
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add HCl to the list of hazardous decomposition products;
2. Disclose on the MSDS that an ingredient in the controlled product has shown mutagenic effects in bacterial cells.
Registry Number 6795
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose the current TWA value of 1 mg/m3 for the ingredient aluminum.
Registry Numbers 6797and 6798
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add HCl to the list of hazardous combustion products;
2. Amend the MSDS to disclose the lower exposure limit of 0.025 mg/m3 for the ingredient silica, quartz.
Registry Number 6799
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose the appropriate concentration or concentration range for an ingredient in the controlled product;
2. Disclose on the MSDS the IARC 2B classification for the ingredient titanium dioxide.
Registry Number 6800
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose the appropriate concentration or concentration range for ingredients in the controlled product;
2. Disclose on the MSDS the IARC 2B classification for the ingredient titanium dioxide.
Registry Number 6809
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the section of the MSDS to also include oxides of nitrogen, hydrogen chloride and hydrogen cyanide as possible hazardous products of combustion;
2. Remove the TLV and TWA designations from the values disclosed on the MSDS as exposure limits for “particulates”.
Registry Number 6813
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B3.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6821
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of carbon to the list of hazardous combustion products.
Registry Numbers 6826 to 6831, inclusive
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an accepted LD50 value according to the regulations;
2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A;
3. Registry Number 6827:
(a) Disclose that eye corrosion has been observed in laboratory animals as a result of eye exposure to an ingredient in the controlled product;
(b) Amend the MSDS to disclose an increased rinse time of at least 30 minutes or until the chemical is removed in the first aid advice for eye contact.
4. Registry Numbers 6826 and 6828:
(a) Add oxides of nitrogen and chlorine to the list of hazardous decomposition or combustion products;
5. Registry Numbers 6827 and 6829:
(a) Add oxides of nitrogen to the list of hazardous decomposition or combustion products.
Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.
Registry Numbers 6849 to 6851, inclusive
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose an ACGIH TLV–TWA of 1 mg/m3 (respirable) for the ingredient aluminum oxide;
2. Amend the MSDS to disclose an ACGIH TLV–TWA of 0.025 mg/m3 (respirable) for the hazardous ingredient cristabolite and the ACGIH A2 notation;
3. Amend the MSDS to disclose that the controlled product may be incompatible with the following materials: halocarbons, chlorine triflouride, ethylene oxide, oxygen diflouride and vinyl acetate.
Registry Number 6852
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add the time frame of 20 minutes to the rinsing recommendation for first aid measures in cases of eye contact.
Registry Number 6854
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add oxides of nitrogen to the list of hazardous thermal decomposition products.
Registry Numbers 6857 and 6858
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an ACGIH TLV–STEL of 6 ppm (15 mg/m3) for the hazardous ingredient monethanolamine;
2. Disclose an AIHA WEEL of 10 ppm (8 hours) for the hazardous ingredient benzyl alcohol;
3. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the skin of laboratory animals;
4. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the eyes of laboratory animals;
5. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush eyes with water for at least 30 minutes;
6. Amend instructions similar to the following to the first aid measures - Instructions on Skin Contact: Immediately flush skin with water for at least 30 minutes;
7. Add instructions similar to the following to the first aid measures - Instructions on Ingestion: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration;
8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
Registry Number 6890
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the identity and concentration of a hazardous ingredient present at 0.7% weight/weight;
2. Disclose that ingestion of an ingredient in the controlled product has been shown to have teratogenic effects on laboratory animals.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6891
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Numbers 6892 and 6893
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add the time frame of at least 30 minutes to the rinsing recommendation for first aid measures to be employed in cases of eye contact;
2. Add the time frame of at least 30 minutes to the washing recommendation for first aid measures to be employed in cases of skin contact.
Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.
Registry Number 6899
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of nitrogen to the list of hazardous decomposition products;
2. Amend the MSDS to disclose that the ingredient aromatic ketones has caused skin sensitization in laboratory animals.
Registry Number 6900
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Amend instructions similar to the following to the first aid measures - Instructions on Eye Contact: Immediately flush with plenty of water for at least 30 minutes.
Registry Number 6927
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the first aid measures - Ingestion subsection on the MSDS to delete the statement to give one or two glasses of water or milk.
Registry Number 6950
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of the ingredient which can be called phosphoric acid esters, amine salt and its concentration in an acceptable WHMIS format;
2. Report that oxides of nitrogen are also hazardous thermal decomposition products.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6955
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose on the MSDS the current ACGIH TLV–TWA value of 50 ppm and TLV–STEL of 100 ppm to the ingredient tetrahydrofuran;
2. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;
3. Amend the MSDS to disclose the correct value of the boiling point of the controlled product;
4. Amend the MSDS to disclose the correct value of the auto-ignition temperature of the controlled product;
5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 6956
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose on the MSDS the current ACGIH TLV–TWA value of 50 ppm and TLV–STEL of 100 ppm to the ingredient tetrahydrofuran;
2. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;
3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 6957
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of methanol in the controlled product, its CAS Registry Number 67-56-1 and its percent concentration;
2. Disclose on the MSDS the ACGIH TLV–TWA value of 20 ppm for the ingredient toluene with no skin notation;
3. Amend the MSDS to advise, in case of ingestion of the controlled product: if breathing has stopped, trained personnel should administer artificial respiration; if the heart has stopped, trained personnel should administer cardio-pulmonary resuscitation;
4. Amend the MSDS to state clearly what are the lower and upper flammable limits for the controlled product;
5. Disclose fumes of HCl as a hazardous combustion product;
6. Disclose on the MSDS that an ingredient in the controlled product causes teratogenic/fetotoxic effects in the absence of maternal toxicity;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 6959
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 6971
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 6972
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add HCl to the list of hazardous combustion products.
Registry Number 7034
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has been shown to cause corrosion to the skin of laboratory animals;
2. Amend the first aid measures - Swallowing subsection on the MSDS to add instructions similar to the following: If vomiting occurs naturally, lean the victim forward to reduce the risk of aspiration;
3. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 7068
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 7077
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend instructions to the first aid measures for eye contact to state: Immediately flush eyes with plenty of water for at least 30 minutes;
2. Amend instructions to the first aid measures for skin contact to state: Immediately flush eyes with plenty of water for at least 30 minutes;
3. Amend instructions to the first aid measures for ingestion to state: If vomiting occurs naturally, have the victim lean forward to reduce the risk of aspiration;
4. Amend the first aid measures pertaining to ingestion by deleting the statement to give water to drink;
5. Disclose an auto-ignition temperature of 340°C for the controlled product.
Registry Number 7082
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend instructions in the first aid measures - Eye Contact to state: Rinse immediately with plenty of water for at least 30 minutes;
2. Amend instructions in the first aid measures - Skin Contact to state: If breathing has stopped, trained personnel should begin artificial respiration (AR) immediately. If the heart has stopped, trained personnel should begin cardio-pulmonary resuscitation (CPR) immediately;
3. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
4. Disclose an LD50 value for another of the confidential hazardous ingredients in an acceptable manner;
5. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
Registry Number 7087
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the MSDS to disclose an LD50 (oral, rat) value for the controlled product with as much precision as possible.
Registry Number 7092
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 7096
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Amend the first aid measures - Ingestion by deleting the statement to give water to drink;
2. Amend instructions in the first aid measures - Eye contact to state: Immediately flush eyes with plenty of water for at least 30 minutes.
Registry Number 7174
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Registry Number 7250
The claimant has been ordered to amend certain aspects of the content of the MSDS.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 6533, 6535, 6536, 6537, 6564, 6592, 6593, 6595, 6596, 6599, 6609, 6614, 6615, 6616, 6697, 6722, 6735, 6736, 6742, 6743, 6746, 6779, 6783, 6809, 6817, 6853, 6859, 6864, 6871, 6887, 6969, 7113, 7249 and 7252, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.
In the case of the claim bearing Registry Number 6533, the screening officer has ordered the claimant to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer, within the respective time period specified in the foregoing paragraph.
In the cases of the claims bearing Registry Numbers 6535, 6536 and 6537, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended label to the screening officer, within the respective time period specified in a foregoing paragraph.
Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS.
Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.
Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-998-2363.
R. BOARDMAN
Chief Screening Officer
[52-1-o]
NATIONAL ENERGY BOARD
APPLICATION TO EXPORT ELECTRICITY TO THE UNITED STATES
British Columbia Transmission Corporation and British Columbia Hydro and Power Authority
By an application dated December 19, 2008, British Columbia Transmission Corporation (the “Applicant”) has applied on behalf of itself and the British Columbia Hydro and Power Authority to the National Energy Board (the “Board”), under Division II of Part VI of the National Energy Board Act (the “Act”), for authorization to make carrier and adjustment transfer exports up to the transfer limits of the high voltage transmission lines in British Columbia that are directly interconnected with the United States for a period of ten years commencing on February 1, 2009. These exports would be in accordance with the Applicant’s role as Balancing Authority for British Columbia and with the Applicant’s Open Access Transmission Tariff approved by the British Columbia Utilities Commission.
The Board wishes to obtain the views of interested parties on this application before issuing a permit or recommending to the Governor in Council that a public hearing be held. The directions on procedure that follow explain in detail the procedure that will be used.
1. The Applicant shall deposit and keep on file, for public inspection during normal business hours, copies of the application at its offices located at Four Bentall Centre, Suite 1100, 1055 Dunsmuir Street, Vancouver, British Columbia V7X 1V5, to the attention of Janet Fraser, 604-699-7318, and provide a copy of the application to any person who requests one. A copy of the application is also available for viewing during normal business hours in the Board’s library, 444 Seventh Avenue SW, Room 1002, Calgary, Alberta T2P 0X8.
2. Submissions that any party wishes to present shall be filed with the Secretary of the Board, 444 Seventh Avenue SW, Calgary, Alberta T2P 0X8, 403-292-5503 (fax), and served on the Applicant by January 26, 2009.
3. Pursuant to subsection 119.06(2) of the Act, the Board shall have regard to all considerations that appear to it to be relevant. In particular, the Board is interested in the views of submitters with respect to
(a) the effect of the exportation of the electricity on provinces other than that from which the electricity is to be exported;
(b) the impact of the exportation on the environment; and
(c) whether the Applicant has
(i) informed those who have declared an interest in buying electricity for consumption in Canada of the quantities and classes of service available for sale, and
(ii) given an opportunity to purchase electricity on terms and conditions as favourable as the terms and conditions specified in the application to those who, within a reasonable time of being so informed, demonstrate an intention to buy electricity for consumption in Canada.
4. Any answer to submissions that the Applicant wishes to present in response to items 2 and 3 of this notice of application and directions on procedure shall be filed with the Secretary of the Board and served on the party that filed the submission by February 10, 2009.
5. For further information on the procedures governing the Board’s examination, contact the Secretary of the Board, Claudine Dutil-Berry, at 403-299-2714 (telephone) or 403-292-5503 (fax).
CLAUDINE DUTIL-BERRY
Secretary
[52-1-o]
NOTICE:
The format of the electronic version of this issue of the Canada Gazette was modified in order to be compatible with extensible hypertext markup language (XHTML 1.0 Strict).
